KRAS and pancreatic ductal adenocarcinoma: K-ras mutations are not identified in ACC, by contrast, activating mutations in the K-ras proto-oncogene are found in almost all cases of pancreatic ductal adenocarcinoma, as well as in early precursor lesions termed pancreatic intraepithelial neoplasia (3,4).